lidoflazine has been researched along with Hemorrhagic Shock in 1 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horton, JW | 1 |
1 other study available for lidoflazine and Hemorrhagic Shock
| Article | Year |
|---|---|
Hemorrhagic shock impairs myocardial cell volume regulation and membrane integrity in dogs.
Topics: Anesthesia; Animals; Calcium; Cell Membrane; Cell Membrane Permeability; Coronary Circulation; Dogs; | 1987 |